AGMB Buy Disclosure
Kemula Pierre Thadee Victor · SEC Form 4 · Filed Oct 7, 2026
Buy
Calculated transaction value
$17.08K
Kemula Pierre Thadee Victor Chief Financial Officer
AGMB
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
AGMB daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common shares
- Quantity / price
- 2,000 shares @ $8.54
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0002119332-26-000001
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$85.94K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Agomab Therapeutics Nv AGMB Current | Buy | Oct 6, 2026 | $17.08K |
| Agomab Therapeutics Nv AGMB | Buy | Oct 6, 2026 | $26.01K |
| Agomab Therapeutics Nv AGMB | Buy | Oct 6, 2026 | $42.85K |